View More Recent Stories

Oct 7, 2024 08:19AM TD Cowen Reiterates Buy Rating on Humacyte (HUMA)

Oct 4, 2024 08:01AM Humacyte (HUMA) Prices 6.58M Share and Warrant Offering at $5.28/sh

Sep 30, 2024 02:54PM TD Cowen Reiterates Buy Rating on Humacyte (HUMA)

Sep 19, 2024 08:02AM Humacyte (HUMA) Announces Allowance of U.S. Patent Covering BioVascular Pancreas

Sep 9, 2024 07:03AM EF Hutton Starts Humacyte (HUMA) at Buy

Sep 5, 2024 07:23AM Benchmark Reiterates Buy Rating on Humacyte (HUMA)

Aug 27, 2024 11:08AM TD Cowen Reiterates Buy Rating on Humacyte (HUMA)

Aug 27, 2024 08:09AM Humacyte (HUMA) Presents Positive Long-Term Results of ATEV in Treatment of Vascular Trauma in Military Setting from Ukraine Humanitarian Program

Aug 13, 2024 09:50AM Humacyte (HUMA) PT Lowered to $10 at BTIG

Aug 13, 2024 07:12AM Humacyte, Inc. (HUMA) Misses Q2 EPS by 24c

Aug 9, 2024 04:05PM Humacyte (HUMA) Announces FDA Communication of Additional Time Required to Complete Review of ATEV BLA

Jul 31, 2024 07:02AM Humacyte (HUMA) Reports ATEV Meets Primary Endpoints in V007 Phase 3 Trial

Jul 16, 2024 08:01AM Humacyte (HUMA) Appoints John P. Bamforth and Keith Anthony Jones to its Board

Jul 9, 2024 10:08AM Humacyte (HUMA) and Pluristyx Enter License Agreement to Develop BioVascular Pancreas using iPSCs

Jul 1, 2024 08:05AM Humacyte (HUMA) Acellular Tissue Engineered Vessel Receives FDA’s RMAT Designation for Patients with Advanced PAD

Jun 25, 2024 02:40PM TD Cowen Reiterates Buy Rating on Humacyte (HUMA)

Jun 17, 2024 03:12PM Humacyte (HUMA) PT Raised to $7.50 at TD Cowen

Jun 17, 2024 08:06AM Humacyte (HUMA): Centers for Medicare & Medicaid Services (CMS) Issues ICD-10-PCS Codes for Humacyte’s Human Acellular Vessel

View More Recent Stories